IGF1 and Alzheimer disease: miR-98 has shown to increase in AD mouse model (Wang et al., 2009) and miR-98 was found to target IGF-1 3′UTR directly leading to the decreased IGF-1 expression at both mRNA and protein levels (Hu et al., 2013).